Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons

Editorial: Structures, Signaling Mechanisms, and Functions of Types I and III Interferons

Bibliographic Details
Main Authors:	Ronald L. Rabin, Mark R. Walter
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Immunology
Subjects:	interferon α interferon λ interferon subtypes interferon receptors interferon structure interferon signaling
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2021.638479/full

Similar Items

The interferons : characterization and application /
by: Meager, Anthony
Published: (2006)

Interferon alpha, gamma, and lambda 2: are they possible culprits in the association between psoriasis and hepatitis C virus?
by: Randa Youssef, et al.
Published: (2019-01-01)

The Key Roles of Interferon Lambda in Human Molecular Defense against Respiratory Viral Infections
by: Alexey A. Lozhkov, et al.
Published: (2020-11-01)

Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes
by: Megen C. Wittling, et al.
Published: (2021-01-01)

Insights Into Type I and III Interferons in Asthma and Exacerbations
by: Helen E. Rich, et al.
Published: (2020-09-01)

IFN signaling: how a non-canonical model led to the development of IFN mimetics
by: Howard M Johnson, et al.
Published: (2013-07-01)

Both Type I and Type II Interferons Can Activate Antitumor M1 Macrophages When Combined With TLR Stimulation
by: Elisabeth Müller, et al.
Published: (2018-11-01)

Importance of Type I and III Interferons at Respiratory and Intestinal Barrier Surfaces
by: Megan L. Stanifer, et al.
Published: (2020-12-01)

Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus
by: I-Tsu Chyuan, et al.
Published: (2019-08-01)

Portrait of a patient with systemic lupus erythematosus for the prescription of the type I interferon inhibitor anifrolumab
by: T. M. Reshetnyak, et al.
Published: (2023-12-01)

Interferons in Traumatic Brain and Spinal Cord Injury: Current Evidence for Translational Application
by: Francesco Roselli, et al.
Published: (2018-06-01)

Rapid achievement of low disease activity during the use of a type I interferon inhibitor in a patient with torpid systemic lupus erythematosus (case report)
by: A. A. Baranov, et al.
Published: (2024-06-01)

Recent Progress in Interferon Therapy for Myeloid Malignancies
by: Fiona M. Healy, et al.
Published: (2021-10-01)

Cross-Species Genome-Wide Analysis Reveals Molecular and Functional Diversity of the Unconventional Interferon-ω Subtype
by: Lauren E. Shields, et al.
Published: (2019-06-01)

Function and Modulation of Type I Interferons during Respiratory Syncytial Virus Infection
by: Laura M. Stephens, et al.
Published: (2020-04-01)

Interferon-λ Attenuates Rabies Virus Infection by Inducing Interferon-Stimulated Genes and Alleviating Neurological Inflammation
by: Yingying Li, et al.
Published: (2020-04-01)

Interferon : [electronic resource]: The 50th Anniversary/
by: 454129 Pitha, Paula M., et al.
Published: (2007)

Neopterin as а Modern Marker of Inflammation
by: R. A. Gladkikh, et al.
Published: (2016-06-01)

Reduced sputum expression of interferon-stimulated genes in severe COPD
by: Hilzendeger C, et al.
Published: (2016-06-01)

Expression of interferon-stimulated genes, but not polymorphisms in the interferon α/β receptor 2 gene, is associated with coronavirus disease 2019 mortality
by: Berliana Hamidah, et al.
Published: (2024-10-01)

Type I interferons augment regulatory T cell polarization in concert with ancillary cytokine signals
by: Siawosh K. Eskandari, et al.
Published: (2023-04-01)

The effectiveness of Interferon-Ophthalmo, an antiviral and immunotropic drug, in the treatment of adenoviral ophthalmic infections
by: E. V. Yani, et al.
Published: (2023-03-01)

Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
by: Yuliya V. Katlinskaya, et al.
Published: (2016-04-01)

Tumour cells can escape antiproliferative pressure by interferon-β through immunoediting of interferon receptor expression
by: Felix Hiebinger, et al.
Published: (2023-12-01)

Type III interferon drives pathogenicity to Staphylococcus aureus via the airway epithelium
by: Silvia Pires, et al.
Published: (2024-07-01)

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
by: Tamarah D. de Jong, et al.
Published: (2019-04-01)

Molde brônquico devido ao uso de interferon peguilado e ribavirina Bronchial casts attributed to the use of pegylated interferon and ribavirin
by: Eduardo Garcia, et al.
Published: (2009-07-01)

Efficacy and safety of the type I interferon receptor inhibitor anifrolumab in patients with systemic lupus erythematosus (results of a 6-month study)
by: T. M. Reshetnyak, et al.
Published: (2024-04-01)

Influence of Canonical and Non-Canonical IFNLR1 Isoform Expression on Interferon Lambda Signaling
by: John Grayson Evans, et al.
Published: (2023-02-01)

In-vivo Activity of IFN-λ and IFN-α Against Bovine-Viral-Diarrhea Virus in a Mouse Model
by: María Eugenia Quintana, et al.
Published: (2020-02-01)

Antiviral Type I and Type III Interferon Responses in the Central Nervous System
by: Thomas Michiels, et al.
Published: (2013-03-01)

Contributions of Ubiquitin and Ubiquitination to Flaviviral Antagonism of Type I IFN
by: Erika Hay-McCullough, et al.
Published: (2021-04-01)

Genetic Polymorphism of Interferon-Gamma +874T/A as a Risk Factor for Pulmonary Tuberculosis in Cirebon, Indonesia
by: Allain Umadela Deuxawalu Kiteswara, et al.
Published: (2024-11-01)

Editorial: Community series in identification, function, and mechanisms of interferon induced genes associated with viruses, volume II
by: Jieying Bai, et al.
Published: (2023-08-01)

The expression of interferon-stimulated genes (interferon “signature”) in patients with rheumatoid arthritis (Preliminary results)
by: A. S. Avdeeva, et al.
Published: (2021-01-01)

Deregulation of Interferon Signaling in Malignant Cells
by: Leonidas C. Platanias, et al.
Published: (2010-02-01)

TLR3 Activation of Hepatic Stellate Cell Line Suppresses HBV Replication in HepG2 Cells
by: Biao Zhang, et al.
Published: (2018-12-01)

Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases
by: Rui Lang, et al.
Published: (2022-10-01)

Editorial: Identification, function and mechanisms of interferon induced genes associated with viruses
by: Linzhu Ren, et al.
Published: (2023-01-01)

Interferon-α Subtypes As an Adjunct Therapeutic Approach for Human Immunodeficiency Virus Functional Cure
by: Jeffy George, et al.
Published: (2018-02-01)